BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31637449)

  • 21. Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.
    Di Gregorio J; Appignani M; Flati V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ubiquitin ligases as cancer targets and biomarkers.
    Sun Y
    Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting neddylation in cancer therapy.
    Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
    Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance.
    Yang L; Chen J; Huang X; Zhang E; He J; Cai Z
    Am J Med Sci; 2018 Apr; 355(4):368-376. PubMed ID: 29661351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer.
    Shiromizu T; Yuge M; Kasahara K; Yamakawa D; Matsui T; Bessho Y; Inagaki M; Nishimura Y
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression.
    Sinha A; Iyengar PV; Ten Dijke P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury.
    Zhou W; Zhong Z; Lin D; Liu Z; Zhang Q; Xia H; Peng S; Liu A; Lu Z; Wang Y; Ye S; Ye Q
    Cell Death Dis; 2021 Feb; 12(2):211. PubMed ID: 33627626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of regulatory ubiquitination in cancer and metastasis.
    Gallo LH; Ko J; Donoghue DJ
    Cell Cycle; 2017 Apr; 16(7):634-648. PubMed ID: 28166483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
    Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
    Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of approaches for screening for ubiquitin ligase inhibitors.
    Sun Y
    Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting ubiquitination for cancer therapies.
    Morrow JK; Lin HK; Sun SC; Zhang S
    Future Med Chem; 2015; 7(17):2333-50. PubMed ID: 26630263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer.
    Tian X; Chen Y; Peng Z; Lin Q; Sun A
    Biochem Pharmacol; 2023 Aug; 214():115641. PubMed ID: 37307883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.
    De Cesare V; Johnson C; Barlow V; Hastie J; Knebel A; Trost M
    Cell Chem Biol; 2018 Sep; 25(9):1117-1127.e4. PubMed ID: 30017913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ITCH as a potential therapeutic target in human cancers.
    Yin Q; Wyatt CJ; Han T; Smalley KSM; Wan L
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):117-130. PubMed ID: 32165318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
    Sun A; Tian X; Chen Y; Yang W; Lin Q
    Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.